An antitrophic effect of somatostatin on intestinal cell renewal could be expected as somatostatin inhibited the release of gastrin and growth hormone, both trophic hormones of the intestine. A chronopharmacological dependence, i.e. a change in the effects as a function of the schedule of injection, was suspected as jejunal cell renewal was characterized by a circadian rhythm of DNA synthesis and mitosis. This study was undertaken to control the inhibiting effect of somatostatin on jejunal cell renewal, to test the pharmacological dependence of the action of somatostatin and whether the antitrophic effect could be related with any change in gastrin secretion. The cell renewal observed by DNA labeling, the count of mitoses on jejunal autohistoradiographies and the plasma gastrin level, determined by radioimmunoassay, were documented in male Wistar rats fasted for 12 h, sacrificed every 4 h from 30 min to 24 ½ h after a single intraperitoneal injection of 40 μg/100 g of somatostatin (cyclic form; Serono). Somatostatin was injected either at 10.30 h near the minimum of DNA labeling and mitosis, or at 22.30 h near the peak of these variables. When injected in the morning, somatostatin decreased the mean number of labeled cells and mitotic figures and disturbed the rhythm. When injected in the evening, somatostatin suppressed the circadian variation of cell renewal without changing the mean level of the variables. Circadian parameters of the plasma gastrin level were modified by the fasting schedule, the mean level was lower and the acrophase was delayed when fasting began during the night but somatostatin administration did not change the gastrin level and its circadian variation. The inhibiting effect of somatostatin on cell renewal was characterized by a chronopharmacological dependence, and was not related to a decrease of the plasma level of gastrin.